Last reviewed · How we verify

sodium carboximethycellulose

Universidade Federal do Rio de Janeiro · FDA-approved active Small molecule

Sodium carboxymethylcellulose is a cellulose derivative that acts as a viscous, water-soluble polymer to provide lubrication, moisture retention, and protective coating of mucosal surfaces.

Sodium carboxymethylcellulose is a cellulose derivative that acts as a viscous, water-soluble polymer to provide lubrication, moisture retention, and protective coating of mucosal surfaces. Used for Dry eye syndrome (artificial tears), Oral mucositis protection, Gastrointestinal mucosal protection.

At a glance

Generic namesodium carboximethycellulose
SponsorUniversidade Federal do Rio de Janeiro
Drug classCellulose derivative; lubricant and protective agent
ModalitySmall molecule
Therapeutic areaOphthalmology; Gastroenterology; Dermatology
PhaseFDA-approved

Mechanism of action

As an anionic polysaccharide, sodium carboxymethylcellulose (CMC-Na) forms a hydrophilic gel layer when dissolved in aqueous solutions. It is used topically or as an excipient to protect and lubricate mucous membranes, reduce friction, and maintain moisture. Its mechanism is primarily physical rather than pharmacological, making it suitable for ophthalmic, oral, and gastrointestinal applications.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: